Refractory Malignant Neoplasm: Clinical Trials

1 trial for Refractory Malignant Neoplasm, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 active not recruiting. 1 Phase 2, 1 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 21Active not recruiting 1
Phase 31Active not recruiting 1

Follow Refractory Malignant Neoplasm: new trials by email Literature Review of Refractory Malignant Neoplasm trials Research Report on Refractory Malignant Neoplasm

Trials (filtered) newest first · largest first

All 1 trial

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Physical Activity and Dexamethasone in Reducing Cancer-Related Fatigue in Patients With Advanced Cancer
Dexamethasone, Exercise Intervention, Laboratory Biomarker Analysis - Advanced Malignant Neoplasm, Fatigue
Phase 2 / Phase 3Active not recruitingM.D. Anderson Cancer Center902015-08-132026-09-22

Narrower conditions

Fatigue (1)  ·  Neoplasm Metastasis (1)  ·  Neoplasms (1)  ·  Recurrence (1)

Broader conditions

Disease Attributes (1)  ·  Neoplastic Processes (1)  ·  Pathologic Processes (1)  ·  Pathological Conditions, Signs and Symptoms (1)  ·  Signs and Symptoms (1)

Interventions

Calcium Dobesilate (1)  ·  Dexamethasone (1)  ·  auricularum (1)  ·  dexamethasone 21-phosphate (1)  ·  dexamethasone acetate (1)

Sponsors

M.D. Anderson Cancer Center (1)

Countries

United States (1)

Top investigators

Sriram Yennu (1)

Results publications

PMID 34965510